Literature DB >> 22585737

PTK7 as a novel marker for favorable gastric cancer patient survival.

Yi Lin1, Lian-Hai Zhang, Xiao-Hong Wang, Xiao-Fang Xing, Xiao-Jing Cheng, Bin Dong, Ying Hu, Hong Du, Ying-Ai Li, Yu-Bing Zhu, Ning Ding, Yun-Xia Du, Ji-You Li, Jia-Fu Ji.   

Abstract

BACKGROUND AND OBJECTIVES: Protein tyrosine kinase 7 (PTK7) plays important functions in several cancer types but its expression in gastric cancer remains unknown. This study was designed to investigate PTK7 expression in gastric cancer.
METHODS: PTK7 expression was assessed by immunohistochemistry in 201 gastric cancer patients. The relationship between PTK7 expression and clinicopathological features and patients prognosis were statistically analyzed.
RESULTS: PTK7 expression was detected in 56.72% (114 of 201) of gastric cancer patients. The immunostaining was predominantly localized in the cytoplasm. The statistical analyses showed that PTK7 expression was more frequently detected in patients with well-differentiated tumors (P = 0.001). Furthermore, PTK7 expression was significantly related to the favorable overall survival (OS; P = 0.012) and disease-free survival (DFS; P = 0.009). Multivariate Cox regression analyses revealed that PTK7 expression was an independent prognostic factor for both favorable OS (P = 0.028) and DFS (P = 0.012).
CONCLUSION: Our findings demonstrate that PTK7 can serve as a novel prognostic biomarker for gastric cancer patients.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585737     DOI: 10.1002/jso.23154

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  20 in total

1.  18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.

Authors:  Orit Jacobson; Ido D Weiss; Lu Wang; Zhe Wang; Xiangyu Yang; Andrew Dewhurst; Ying Ma; Guizhi Zhu; Gang Niu; Dale O Kiesewetter; Neil Vasdev; Steven H Liang; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2015-08-27       Impact factor: 10.057

2.  A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma.

Authors:  Ron Chen; Purvesh Khatri; Pawel K Mazur; Melanie Polin; Yanyan Zheng; Dedeepya Vaka; Chuong D Hoang; Joseph Shrager; Yue Xu; Silvestre Vicent; Atul J Butte; E Alejandro Sweet-Cordero
Journal:  Cancer Res       Date:  2014-03-20       Impact factor: 12.701

3.  PTK7 expression is associated with lymph node metastasis, ALK and EGFR mutations in lung adenocarcinomas.

Authors:  Wei Jiang; Jing He; Bihong Lv; Xiaoxiang Xi; Guangming He; Jingkang He
Journal:  Histol Histopathol       Date:  2019-11-08       Impact factor: 2.303

4.  Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors.

Authors:  Shanta M Messerli; Mariah M Hoffman; Etienne Z Gnimpieba; Ratan D Bhardwaj
Journal:  Mol Cancer Res       Date:  2017-04-25       Impact factor: 5.852

5.  Antibody-drug conjugate targeting protein tyrosine kinase 7, a receptor tyrosine kinase-like molecule involved in WNT and vascular endothelial growth factor signaling: effects on cancer stem cells, tumor microenvironment and whole-body homeostasis.

Authors:  Masaru Katoh
Journal:  Ann Transl Med       Date:  2017-12

6.  PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis.

Authors:  Haiyan Wang; Guimei Li; Yongxiang Yin; Jianjun Wang; Hai Wang; Wei Wei; Qing Guo; Henghui Ma; Qunli Shi; Xiaojun Zhou; Jiandong Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

7.  Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.

Authors:  Anne-Catherine Lhoumeau; Sébastien Martinez; Jean-Marie Boher; Geneviève Monges; Rémy Castellano; Armelle Goubard; Marie Doremus; Flora Poizat; Bernard Lelong; Cécile de Chaisemartin; Florence Bardin; Patrice Viens; Jean-Luc Raoul; Thomas Prebet; Michel Aurrand-Lions; Jean-Paul Borg; Anthony Gonçalves
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

8.  PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement.

Authors:  Silvia Gärtner; Angela Gunesch; Tatiana Knyazeva; Petra Wolf; Bernhard Högel; Wolfgang Eiermann; Axel Ullrich; Pjotr Knyazev; Beyhan Ataseven
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

9.  PTK7 promotes the malignant properties of cancer stem-like cells in esophageal squamous cell lines.

Authors:  Jun Bie; Xin Hu; Mi Yang; Xianwei Shi; Xinping Zhang; Ziwei Wang
Journal:  Hum Cell       Date:  2020-01-01       Impact factor: 4.374

10.  Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.

Authors:  Yansheng Liu; Jing Chen; Atul Sethi; Qing K Li; Lijun Chen; Ben Collins; Ludovic C J Gillet; Bernd Wollscheid; Hui Zhang; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2014-04-16       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.